LEXICON PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Lexicon Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Lexicon Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 67.5 %, a 14.4% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 67.5 -11.4 -14.4% Sep 30, 2024
Q2 2024 70.3 +8.67 +14.1% Jun 30, 2024
Q1 2024 75.2 +17.8 +31% Mar 31, 2024
Q4 2023 94.3 +44.9 +90.9% Dec 31, 2023
Q3 2023 78.9 +41.9 +113% Sep 30, 2023
Q2 2023 61.6 +26.8 +77% Jun 30, 2023
Q1 2023 57.4 +28.9 +101% Mar 31, 2023
Q4 2022 49.4 +24.6 +98.8% Dec 31, 2022
Q3 2022 37 +9.87 +36.3% Sep 30, 2022
Q2 2022 34.8 -5.25 -13.1% Jun 30, 2022
Q1 2022 28.5 -104 -78.5% Mar 31, 2022
Q4 2021 24.9 -249 -90.9% Dec 31, 2021
Q3 2021 27.2 -391 -93.5% Sep 30, 2021
Q2 2021 40.1 -337 -89.4% Jun 30, 2021
Q1 2021 133 -307 -69.8% Mar 31, 2021
Q4 2020 273 -417 -60.4% Dec 31, 2020
Q3 2020 418 -3.88K -90.3% Sep 30, 2020
Q2 2020 377 +1.13K Jun 30, 2020
Q1 2020 440 +1.65K Mar 31, 2020
Q4 2019 691 +4.58K Dec 31, 2019
Q3 2019 4.3K +1.96K +83.4% Sep 30, 2019
Q2 2019 -753 -1.54K -196% Jun 30, 2019
Q1 2019 -1.21K -1.66K -374% Mar 31, 2019
Q4 2018 -3.89K -4.18K -1424% Dec 31, 2018
Q3 2018 2.34K +2.12K +949% Sep 30, 2018
Q2 2018 786 +589 +299% Jun 30, 2018
Q1 2018 443 +265 +149% Mar 31, 2018
Q4 2017 294 +130 +79.1% Dec 31, 2017
Q3 2017 224 +75.1 +50.6% Sep 30, 2017
Q2 2017 197 +65 +49.3% Jun 30, 2017
Q1 2017 178 +63.9 +56.1% Mar 31, 2017
Q4 2016 164 +68.3 +71.4% Dec 31, 2016
Q3 2016 148 +71 +91.6% Sep 30, 2016
Q2 2016 132 +53.3 +67.9% Jun 30, 2016
Q1 2016 114 +33.5 +41.7% Mar 31, 2016
Q4 2015 95.7 +13.8 +16.8% Dec 31, 2015
Q3 2015 77.5 -6.42 -7.65% Sep 30, 2015
Q2 2015 78.6 +8.8 +12.6% Jun 30, 2015
Q1 2015 80.4 +20.1 +33.4% Mar 31, 2015
Q4 2014 81.9 +28.9 +54.5% Dec 31, 2014
Q3 2014 83.9 +36.4 +76.5% Sep 30, 2014
Q2 2014 69.8 +26.4 +60.9% Jun 30, 2014
Q1 2014 60.3 +15.4 +34.4% Mar 31, 2014
Q4 2013 53 +6.55 +14.1% Dec 31, 2013
Q3 2013 47.5 -0.22 -0.46% Sep 30, 2013
Q2 2013 43.4 -10.5 -19.5% Jun 30, 2013
Q1 2013 44.9 -10.4 -18.8% Mar 31, 2013
Q4 2012 46.5 Dec 31, 2012
Q3 2012 47.7 Sep 30, 2012
Q2 2012 53.8 Jun 30, 2012
Q1 2012 55.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.